SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-020569
Filing Date
2018-11-13
Accepted
2018-11-13 16:10:19
Documents
3
Period of Report
2018-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atos20181112_8k.htm 8-K 70444
2 EXHIBIT 99.1 ex_129431.htm EX-99.1 145093
3 ex_129431img001.gif GRAPHIC 6546
  Complete submission text file 0001437749-18-020569.txt   225887
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA GENETICS INC (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35610 | Film No.: 181178042
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences